Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tilray Inc (TLRY.TO)

Tilray Inc (TLRY.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,026,914
  • Shares Outstanding, K 1,122,863
  • Annual Sales, $ 821,309 K
  • Annual Income, $ -2,187 M
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 3.64
  • Price/Sales 1.35
  • Price/Cash Flow N/A
  • Price/Book 0.94
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -2.42
  • Most Recent Earnings $0.00 on 10/09/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    TSX Drug Specialty & Generic

Options Overview Details

View History
  • Implied Volatility 129.63% ( +3.86%)
  • Historical Volatility 174.16%
  • IV Percentile 66%
  • IV Rank 38.85%
  • IV High 316.87% on 04/07/25
  • IV Low 10.67% on 08/04/25
  • Put/Call Vol Ratio 0.00
  • Today's Volume 90
  • Volume Avg (30-Day) 481
  • Put/Call OI Ratio 0.22
  • Today's Open Interest 17,396
  • Open Int (30-Day) 17,682

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.69 unch
on 11/06/25
3.23 -47.68%
on 10/09/25
-0.51 (-23.18%)
since 10/06/25
3-Month
0.86 +96.51%
on 08/07/25
3.23 -47.68%
on 10/09/25
+0.84 (+98.82%)
since 08/06/25
52-Week
0.49 +244.90%
on 06/23/25
3.23 -47.68%
on 10/09/25
-0.46 (-21.40%)
since 11/06/24

Most Recent Stories

More News
Tilray Medical Sets the Standard for Compassionate Pricing, Broadening Access to Medical Cannabis for Patients, Seniors, First Responders, and Veterans Through Expanded Pricing Programs Across Canada

LEAMINGTON, Ontario, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic...

TLRY.TO : 1.69 (-7.14%)
TLRY : 1.2100 (-5.47%)
Tilray Brands Sets Sights on Asia: Bringing Award-Winning Craft Beers to Japan’s Premier American Craft Beer Experience Festival

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and...

TLRY.TO : 1.69 (-7.14%)
TLRY : 1.2100 (-5.47%)
Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard Work

SEATTLE, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Redhook Brewing , creator of the hardest working beer in the fridge and a craft brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global lifestyle...

TLRY.TO : 1.69 (-7.14%)
TLRY : 1.2100 (-5.47%)
Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World’s Largest Federally Legal Cannabis Market

TORONTO, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the global...

TLRY.TO : 1.69 (-7.14%)
TLRY : 1.2100 (-5.47%)
Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth

NEW YORK, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic...

TLRY.TO : 1.69 (-7.14%)
TLRY : 1.2100 (-5.47%)
Tilray Brands Reports Strong First Quarter Fiscal 2026 Results, Highlighting Continued Growth with Record Q1 Net Revenue of $210 Million and Net Income

Operational Efficiencies and Focus on Profitability Drove Net Income of  $1.5 Million, Adjusted EBITDA Increased 9% to $10 Million and Net Cash Used in Operations Improved by $34 Million...

TLRY.TO : 1.69 (-7.14%)
TLRY : 1.2100 (-5.47%)
Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings

NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic...

TLRY.TO : 1.69 (-7.14%)
TLRY : 1.2100 (-5.47%)
Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on October 9, 2025

NEW YORK and LEAMINGTON, Ontario, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods...

TLRY.TO : 1.69 (-7.14%)
TLRY : 1.2100 (-5.47%)
Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfest-Inspired Lineup

ATLANTA, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a leading global lifestyle and consumer packaged goods company, is raising a stein to the season with...

TLRY.TO : 1.69 (-7.14%)
TLRY : 1.2100 (-5.47%)
Broken Coast Cannabis Brand Launches Premium and Limited BC Selects Line and Unveils New Strain “Sprits 26”, Elevates Craft Portfolio with Modern Blue Dream Release

NANAIMO, British Columbia, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a leading lifestyle and consumer-packaged goods company, announced that its...

TLRY.TO : 1.69 (-7.14%)
TLRY : 1.2100 (-5.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly...

See More

Key Turning Points

3rd Resistance Point 1.87
2nd Resistance Point 1.84
1st Resistance Point 1.76
Last Price 1.69
1st Support Level 1.65
2nd Support Level 1.62
3rd Support Level 1.54

See More

52-Week High 3.23
Fibonacci 61.8% 2.18
Fibonacci 50% 1.86
Last Price 1.69
Fibonacci 38.2% 1.54
52-Week Low 0.49

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar